Immunic Q4 EPS $(0.07) Beats $(0.09) Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings BeatsNews
Immunic (NASDAQ:IMUX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.09) by 18.6 percent. This is a 72 percent increase over losses of $(0.25) per share from the same
Immunic (NASDAQ:IMUX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.09) by 18.6 percent. This is a 72 percent increase over losses of $(0.25) per share from the same period last year.